Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy

被引:1166
作者
Sica, A [1 ]
Schioppa, T
Mantovani, A
Allavena, P
机构
[1] Ist Clin Humanitas, I-20089 Milan, Italy
[2] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
[3] Univ Milan, Inst Gen Pathol, Ctr IDET, I-20133 Milan, Italy
关键词
TAM; cancer; inflammation;
D O I
10.1016/j.ejca.2006.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour-associated macrophages (TAM) represent the major inflammatory component of the stroma of many turnours, and can affect different aspects of the neoplastic tissue. Many observations indicate that TAM express several M2-associated pro-tumoural functions, including promotion of angiogenesis, matrix remodelling and suppression of adaptive immunity. The pro-tumoural role of TAM in cancer is further supported by clinical studies that found a correlation between the high macrophage content of tumours and poor patient prognosis. Evidence is presented here supporting the view that TAM represent a unique and distinct M2-skewed myeloid population and are a potential target for anti-cancer therapy. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:717 / 727
页数:11
相关论文
共 105 条
[1]   A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells [J].
Adema, GJ ;
Hartgers, F ;
Verstraten, R ;
deVries, E ;
Marland, G ;
Menon, S ;
Foster, J ;
Xu, YM ;
Nooyen, P ;
McClanahan, T ;
Bacon, KB ;
Figdor, CG .
NATURE, 1997, 387 (6634) :713-717
[2]  
Adini A, 2002, CANCER RES, V62, P2749
[3]  
Aharinejad S, 2002, CANCER RES, V62, P5317
[4]   Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production [J].
Allavena, P ;
Signorelli, M ;
Chieppa, M ;
Erba, E ;
Bianchi, G ;
Marchesi, F ;
Olimpio, CO ;
Bonardi, C ;
Garbi, A ;
Lissoni, A ;
de Brand, F ;
Jimeno, J ;
D'Incalci, M .
CANCER RESEARCH, 2005, 65 (07) :2964-2971
[5]   The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues [J].
Allavena, P ;
Sica, A ;
Vecchi, A ;
Locati, M ;
Sozzani, S ;
Mantovani, A .
IMMUNOLOGICAL REVIEWS, 2000, 177 :141-149
[6]  
Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101
[7]  
Ardavin Carlos, 2004, Immunity, V20, P17, DOI 10.1016/S1074-7613(03)00352-2
[8]   The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors [J].
Azenshtein, E ;
Meshel, T ;
Shina, S ;
Barak, N ;
Keydar, I ;
Ben-Baruch, A .
CANCER LETTERS, 2005, 217 (01) :73-86
[9]  
Azenshtein E, 2002, CANCER RES, V62, P1093
[10]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550